Abbott's Volt™ System Gains FDA Approval for Atrial Fibrillation Treatment
TL;DR
Abbott's Volt™ Pulsed Field Ablation System has received FDA approval to treat atrial fibrillation, offering a minimally invasive, effective, and safer option for patients, with clinical trials demonstrating strong safety and efficacy results.
Topics:businesshealthcare#abbott#atrial-fibrillation#cardiac-ablation#fda-approval#healthcare#volt-pfa-system
Want the full story? Read the original reporting
Read on Abbott MediaRoom